Consumer
San Diego, California-based GreatCall, which makes easy to use smartphones and flip phones for seniors, has added automated fall detection to GreatCall Splash, the company's waterproof mobile personal emergency response (mPERS) device.
Los Angeles-based Heal, which has developed an app that helps people send a doctor to their house, has launched its service in San Francisco.
Scanadu has raised $35 million from Fosun International and Tencent Holdings Limited, with participation from China Broadband Capital and iGlobe Partners of Singapore.
Toronto-based InteraXon has raised $11 million for its smartphone-connected brainwave sensing device, called Muse, according to an SEC filing.
Seed fund Rock Health has invested in three new companies: telepsychiatry service 1DocWay, provider analytics company Arsenal Health, and wearable technology maker Caeden.
Mayo Clinic's Apple Watch app for doctors
As the Apple Watch begins to find its way into the hands of consumers, it's also becoming clearer that there's a lot of interest in the health features of the device.
A survey of more than 1,000 consumers from ON World showed that fitness is the most important application for wearable users.
Glow has announced that its fertility tracking app will now help men track and troubleshoot their fertility as well.
Under Armour continues to grow its membership base for what it's calling its Connected Fitness business -- the three apps the company acquired in the past two years as well as its existing UA Record app -- even as the company explores its new acquisitions and plots a course forward, according to the company's first quarter earnings call.
Two of the biggest medical journals in the world have taken up some big picture mobile health questions this week: How are patients to know which medical apps work out of the sea of available options, and should healthy patients be making use of mobile health apps and devices at all?
The first question is the subject of a recent article in the Journal of the American Medical Association, while the second is tackled in a point-counterpoint discussion in the British Medical Journal.